Medical Tourism · Tijuana
The decision to travel across an international border for medical treatment is not one patients make lightly. It requires research, trust, and a willingness to step outside the familiar healthcare systems they have spent years navigating. Yet for thousands of patients with chronic Lyme disease, that step — specifically across the border from San Diego into Tijuana, Mexico — has represented a genuine turning point in their recovery.
The reason is straightforward: the treatments most appropriate for chronic Lyme disease are simply not widely available in the United States. Understanding why requires examining both the science of what these treatments are and the regulatory and logistical environment that determines where they can be offered.
In the United States, the medical and regulatory environment for chronic Lyme disease care is shaped by a complex interplay of institutional guidelines, regulatory requirements, and insurance structures that have historically limited access to advanced treatments.
Systemic Perfusion Hyperthermia — which requires specialized equipment, trained medical teams, hospital-level monitoring, and a structured protocol — is available at a small number of facilities in Europe and Mexico, but is not yet widely offered in US clinical settings. Therapeutic Apheresis exists in the US primarily for specific FDA-approved indications that do not include chronic Lyme disease in their labeling, making access and insurance coverage extremely limited. Autologous T-Regulatory Cell therapy is in early clinical development for several immune-mediated conditions but is not yet available as an integrated clinical offering for Lyme patients at most US centers.
The result is that patients who need these treatments — and whose disease presentation clearly warrants advanced immune-focused intervention — have no practical access to them within the US healthcare system. Tijuana, located immediately across the border from San Diego, has emerged as one of the most accessible centers in North America where these treatments are offered in a coordinated, medically supervised program.
Many patients who have never crossed the US-Mexico border assume that traveling to Tijuana for medical care involves significant logistical complexity. In practice, for patients coming from the western United States, the journey is remarkably straightforward.
San Diego International Airport (SAN) is the primary entry point for most patients, and it is one of the most accessible airports in the US — well-served from major cities across the country. From San Diego International Airport, our dedicated driver picks patients up at arrivals and handles the full journey to the center — including the border crossing. Most patients arrive at the clinic within 45–60 minutes of landing, without any of the logistical complexity of a self-managed border crossing. Tijuana's Zona Urbana Rio district — where the Lyme Immunotherapy Center is located — is a modern, developed medical and commercial district immediately accessible from the border crossing.
For patients who prefer not to navigate the crossing independently, our 18-Day Comprehensive Protocol includes roundtrip airport and clinic transportation. We also maintain a partnership with Quartz Hotel and Spa — a 5-star medical tourism hotel designed around patient wellness and recovery — where our patients receive preferred rates during their program stay.
Practical note: US citizens do not require a visa to enter Mexico for medical stays. A valid US passport is required. Most patients find the crossing straightforward, particularly at Otay Mesa, which has dedicated lanes and efficient processing for medical visitors.
The Lyme Immunotherapy Center offers something that is genuinely difficult to access in one place elsewhere: a coordinated, physician-supervised protocol that integrates Systemic Perfusion Hyperthermia, Therapeutic Apheresis, autologous T-Regulatory Cell therapy, targeted IV protocols, and comprehensive supportive care — all under the oversight of a multidisciplinary medical team with daily physician contact.
In the US healthcare system, even patients fortunate enough to locate individual practitioners offering some of these therapies in isolation face the challenge of fragmentation: diagnostics in one location, a treatment procedure in another, follow-up limited by scheduling, and the individual therapies not coordinated with each other or sequenced in a way that maximizes their combined effect.
Integration matters. Apheresis performed before hyperthermia creates a more receptive physiologic environment for the thermal intervention. Treg therapy introduced after initial detoxification and pathogen reduction operates in a more favorable immune landscape. IV protocols sequenced to support each phase of treatment provide cellular support at the moments it is most needed. This level of coordination is what a structured residential program makes possible — and it is what most patients with complex chronic Lyme have never had access to.
One of the most common concerns patients have about seeking care outside the US is the question of medical standards. It is a legitimate question — and one that deserves a direct answer.
The Lyme Immunotherapy Center operates with hospital-grade equipment and protocols. Our medical team includes functional medicine physicians, clinical specialists with experience in immunotherapy and advanced treatment modalities, registered nurses, clinical nutritionists, physiotherapists, and psychologists. All advanced procedures are performed with continuous monitoring and full physiologic support. Patient safety and informed consent are central to every aspect of our program design.
The regulatory environment in Mexico allows the medical community to offer treatments that have clear scientific rationale and documented clinical experience in international settings — even where US regulatory approval processes have not yet been completed. This is not a loosening of standards; it is a different regulatory framework that prioritizes access to clinically grounded interventions for patients who need them.
Our patients come from across the United States — California, Texas, the Pacific Northwest, the Southeast, the Midwest — as well as from Canada and other countries. They share a common profile: they have been ill for a significant period, they have tried multiple treatment approaches without adequate resolution, and they have reached the point where they are willing to invest seriously in finding a different answer.
For many of them, the journey to Tijuana is not a last resort born of desperation. It is a deliberate, informed choice made after extensive research — a recognition that the treatments they need simply are not available where they live, and that access to those treatments is worth the travel.
Check your eligibility and speak with our case manager about what to expect before, during, and after your program.
Check My Eligibility